A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Biological Activity, and PK of ND L02 s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
|Effective start/end date||10/2/18 → 1/1/22|
- NITTO DENKO TECH CORP
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.